Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery diseaseShow others and affiliations
2022 (English)In: Journal of Nuclear Cardiology, ISSN 1071-3581, E-ISSN 1532-6551, Vol. 29, no 1, p. 24-36Article in journal (Refereed) Published
Abstract [en]
BACKGROUND: The aim of the present study was to compare the quantitative flow responses of regadenoson against adenosine using cardiac 15O-water PET imaging in patients with suspected or known coronary artery disease (CAD).
METHODS: Hyperemic myocardial blood flow (MBF) after adenosine and regadenoson was compared using correlation and Bland-Altman analysis in 21 patients who underwent rest and adenosine 15O-water PET scans followed by rest and regadenoson 15O-water PET scans.
RESULTS: Global mean (± SD) MBF values at rest and stress were 0.92 ± 0.27 and 2.68 ± 0.80 mL·g·min for the adenosine study and 0.95 ± 0.29 and 2.76 ± 0.79 mL·g·min for the regadenoson study (P = 0.55 and P = 0.49). The correlations between global and regional adenosine- and regadenoson-based stress MBF were strong (r = 0.80 and r = 0.77). The biases were small for both global and regional MBF comparisons (0.08 and 0.09 mL·min·g), but the limits of agreement were wide for stress MBF.
CONCLUSION: The correlation between regadenoson- and adenosine-induced hyperemic MBF was strong but the agreement was only moderate indicating that established cut-off values for 150-water PET should be used cautiously if using regadenoson as vasodilator.
Place, publisher, year, edition, pages
2022. Vol. 29, no 1, p. 24-36
Keywords [en]
Modalities, Myocardial blood flow, Vasodilators
National Category
Cardiology and Cardiovascular Disease Radiology, Nuclear Medicine and Medical Imaging
Identifiers
URN: urn:nbn:se:uu:diva-456082DOI: 10.1007/s12350-021-02731-6ISI: 000684463900005PubMedID: 34386859OAI: oai:DiVA.org:uu-456082DiVA, id: diva2:1603227
Funder
Uppsala University2021-10-142021-10-142025-02-10Bibliographically approved